Anthera Pharmace Stock Price, News & Analysis
Company Description
Anthera Pharmace (OTC Link: ANTH) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $617.8K.
ANTH stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of ANTH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Anthera Pharmace (ANTH) stock last traded at $0.0000. At a market capitalization of $617.8K, ANTH is classified as a micro-cap stock with approximately 26.2M shares outstanding.
Latest News
Anthera Pharmace has 1 recent news article. Key topics include acquisition. View all ANTH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Anthera Pharmace (ANTH) currently stands at 3.0 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 10.4%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Anthera Pharmace (ANTH) currently stands at 1.0 days, down 47.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 27.2 days.
ANTH Company Profile & Sector Positioning
Anthera Pharmace (ANTH) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ANTH often look at related companies in the same sector, including Theralink Technologies Inc (THER), Claritas Pharmac (CLAZF), Regen Biopharma (RGBP), Hepion Pharmaceuticals Inc (HEPA), and SYBLEU Inc (SYBE). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ANTH's relative position within its industry.